Supplier
NOVARTIS FARMA SPA
Milano · ITA
Track this recordFree account — get alerted when a contract here runs out.
Awards
9
Total awarded
€16.5m
9 / 9 with a value
Buyers
3
Sectors
2
Group: NOVARTIS FARMA SPA
Reg. 07195130153
Contracts this supplier holds that are running out
- €7,422,260
21 Nov 2026
estimated - €333,250
21 Nov 2026
estimated - €424,852
21 Nov 2026
estimated - €4,319,454
21 Nov 2026
estimated - €2,056,631
21 Nov 2026
estimated - €378
27 Feb 2027
estimated - €264,000
29 Jun 2028
estimated - €316,800
29 Jun 2028
estimated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| GOZETOTIDE | ASL Latina | NOVARTIS FARMA SPA | €316,800 | 1 Jul 2026 |
| EDOTREODITE | ASL Latina | NOVARTIS FARMA SPA | €264,000 | 1 Jul 2026 |
| OXCARBAZEPINA | Azienda Policlinico Tor Vergata | NOVARTIS FARMA SPA | €378 | 26 Feb 2026 |
| OMALIZUMAB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €2,056,631 | 20 Nov 2025 |
| SECUKINUMAB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €4,319,454 | 20 Nov 2025 |
| CAPMATINIB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €424,852 | 20 Nov 2025 |
| ALPELISIB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €333,250 | 20 Nov 2025 |
| RUXOLITINIB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €7,422,260 | 20 Nov 2025 |
| ASCIMINIB | PuntoZero S.c.ar.l. | NOVARTIS FARMA SPA | €1,316,628 | 17 Jun 2025 |